ID   DPM1_HUMAN              Reviewed;         260 AA.
AC   O60762; O15157; Q6IB78; Q96HK0;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   12-APR-2017, entry version 165.
DE   RecName: Full=Dolichol-phosphate mannosyltransferase subunit 1;
DE            EC=2.4.1.83;
DE   AltName: Full=Dolichol-phosphate mannose synthase subunit 1;
DE            Short=DPM synthase subunit 1;
DE   AltName: Full=Dolichyl-phosphate beta-D-mannosyltransferase subunit 1;
DE   AltName: Full=Mannose-P-dolichol synthase subunit 1;
DE            Short=MPD synthase subunit 1;
GN   Name=DPM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Placenta;
RX   PubMed=9535917; DOI=10.1074/jbc.273.15.9249;
RA   Tomita S., Inoue N., Maeda Y., Ohishi K., Takeda J., Kinoshita T.;
RT   "A homologue of Saccharomyces cerevisiae Dpm1p is not sufficient for
RT   synthesis of dolichol-phosphate-mannose in mammalian cells.";
RL   J. Biol. Chem. 273:9249-9254(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-260.
RX   PubMed=9223280; DOI=10.1073/pnas.94.15.7873;
RA   Colussi P.A., Taron C.H., Mack J.C., Orlean P.;
RT   "Human and Saccharomyces cerevisiae dolichol phosphate mannose
RT   synthases represent two classes of the enzyme, but both function in
RT   Schizosaccharomyces pombe.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7873-7878(1997).
RN   [7]
RP   SUBUNIT.
RX   PubMed=10835346; DOI=10.1093/emboj/19.11.2475;
RA   Maeda Y., Tanaka S., Hino J., Kangawa K., Kinoshita T.;
RT   "Human dolichol-phosphate-mannose synthase consists of three subunits,
RT   DPM1, DPM2 and DPM3.";
RL   EMBO J. 19:2475-2482(2000).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   INTERACTION WITH DPM3.
RX   PubMed=16280320; DOI=10.1074/jbc.M511311200;
RA   Ashida H., Maeda Y., Kinoshita T.;
RT   "DPM1, the catalytic subunit of dolichol-phosphate mannose synthase,
RT   is tethered to and stabilized on the endoplasmic reticulum membrane by
RT   DPM3.";
RL   J. Biol. Chem. 281:896-904(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-9, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-9, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND SER-9, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   VARIANT CDG1E GLY-92.
RX   PubMed=10642597; DOI=10.1172/JCI7302;
RA   Kim S., Westphal V., Srikrishna G., Mehta D.P., Peterson S.,
RA   Filiano J., Karnes P.S., Patterson M.C., Freeze H.H.;
RT   "Dolichol phosphate mannose synthase (DPM1) mutations define
RT   congenital disorder of glycosylation Ie (CDG-Ie).";
RL   J. Clin. Invest. 105:191-198(2000).
RN   [19]
RP   VARIANT CDG1E GLY-92.
RX   PubMed=10642602; DOI=10.1172/JCI8691;
RA   Imbach T., Schenk B., Schollen E., Burda P., Stutz A., Gruenewald S.,
RA   Bailie N.M., King M.D., Jaeken J., Matthijs G., Berger E.G., Aebi M.,
RA   Hennet T.;
RT   "Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital
RT   disorder of glycosylation type Ie.";
RL   J. Clin. Invest. 105:233-239(2000).
RN   [20]
RP   VARIANT CDG1E PRO-248.
RX   PubMed=15669674; DOI=10.1023/B:BOLI.0000042984.42433.d8;
RA   Garcia-Silva M.T., Matthijs G., Schollen E., Cabrera J.C.,
RA   Sanchez Del Pozo J., Herreros M.M., Simon R., Maties M.,
RA   Hernandez E.M., Hennet T., Briones P.;
RT   "Congenital disorder of glycosylation (CDG) type Ie. A new patient.";
RL   J. Inherit. Metab. Dis. 27:591-600(2004).
RN   [21]
RP   VARIANT CDG1E VAL-152, AND CHARACTERIZATION OF VARIANT CDG1E VAL-152.
RX   PubMed=23856421; DOI=10.1016/j.ymgme.2013.06.016;
RA   Yang A.C., Ng B.G., Moore S.A., Rush J., Waechter C.J., Raymond K.M.,
RA   Willer T., Campbell K.P., Freeze H.H., Mehta L.;
RT   "Congenital disorder of glycosylation due to DPM1 mutations presenting
RT   with dystroglycanopathy-type congenital muscular dystrophy.";
RL   Mol. Genet. Metab. 110:345-351(2013).
CC   -!- FUNCTION: Transfers mannose from GDP-mannose to dolichol
CC       monophosphate to form dolichol phosphate mannose (Dol-P-Man) which
CC       is the mannosyl donor in pathways leading to N-glycosylation,
CC       glycosyl phosphatidylinositol membrane anchoring, and O-
CC       mannosylation of proteins; catalytic subunit of the dolichol-
CC       phosphate mannose (DPM) synthase complex.
CC   -!- CATALYTIC ACTIVITY: GDP-mannose + dolichyl phosphate = GDP +
CC       dolichyl D-mannosyl phosphate.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the dolichol-phosphate mannose (DPM)
CC       synthase complex composed of DPM1, DPM2 and DPM3; in the complex
CC       interacts directly with DPM3. {ECO:0000269|PubMed:10835346,
CC       ECO:0000269|PubMed:16280320}.
CC   -!- INTERACTION:
CC       Q9P2X0:DPM3; NbExp=4; IntAct=EBI-719526, EBI-9087337;
CC       P48775:TDO2; NbExp=6; IntAct=EBI-719526, EBI-743494;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum.
CC   -!- DISEASE: Congenital disorder of glycosylation 1E (CDG1E)
CC       [MIM:608799]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. Some CDG1E patients have features consistent with
CC       a dystroglycanopathy and congenital muscular dystrophy, including
CC       O-mannosylation defect, camptodactyly, elevated creatine kinase,
CC       motor delay and dystrophic changes on muscel biopsy.
CC       {ECO:0000269|PubMed:10642597, ECO:0000269|PubMed:10642602,
CC       ECO:0000269|PubMed:15669674, ECO:0000269|PubMed:23856421}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D86198; BAA25646.1; -; mRNA.
DR   EMBL; D86202; BAA25647.1; -; Genomic_DNA.
DR   EMBL; CR456926; CAG33207.1; -; mRNA.
DR   EMBL; AK289569; BAF82258.1; -; mRNA.
DR   EMBL; AL034553; CAB53749.1; -; Genomic_DNA.
DR   EMBL; BC007073; AAH07073.1; -; mRNA.
DR   EMBL; BC008466; AAH08466.1; -; mRNA.
DR   EMBL; BC016322; AAH16322.1; -; mRNA.
DR   EMBL; AF007875; AAC98797.1; -; mRNA.
DR   CCDS; CCDS13434.1; -.
DR   RefSeq; NP_001303963.1; NM_001317034.1.
DR   RefSeq; NP_001303964.1; NM_001317035.1.
DR   RefSeq; NP_001303965.1; NM_001317036.1.
DR   RefSeq; NP_003850.1; NM_003859.2.
DR   UniGene; Hs.654951; -.
DR   ProteinModelPortal; O60762; -.
DR   SMR; O60762; -.
DR   BioGrid; 114340; 24.
DR   IntAct; O60762; 28.
DR   STRING; 9606.ENSP00000360644; -.
DR   CAZy; GT2; Glycosyltransferase Family 2.
DR   iPTMnet; O60762; -.
DR   PhosphoSitePlus; O60762; -.
DR   BioMuta; DPM1; -.
DR   EPD; O60762; -.
DR   MaxQB; O60762; -.
DR   PaxDb; O60762; -.
DR   PeptideAtlas; O60762; -.
DR   PRIDE; O60762; -.
DR   DNASU; 8813; -.
DR   Ensembl; ENST00000371588; ENSP00000360644; ENSG00000000419.
DR   GeneID; 8813; -.
DR   KEGG; hsa:8813; -.
DR   UCSC; uc002xvw.2; human.
DR   CTD; 8813; -.
DR   DisGeNET; 8813; -.
DR   GeneCards; DPM1; -.
DR   GeneReviews; DPM1; -.
DR   HGNC; HGNC:3005; DPM1.
DR   HPA; HPA051818; -.
DR   MalaCards; DPM1; -.
DR   MIM; 603503; gene.
DR   MIM; 608799; phenotype.
DR   neXtProt; NX_O60762; -.
DR   OpenTargets; ENSG00000000419; -.
DR   Orphanet; 79322; DPM1-CDG.
DR   PharmGKB; PA27463; -.
DR   eggNOG; KOG2978; Eukaryota.
DR   eggNOG; COG0463; LUCA.
DR   GeneTree; ENSGT00550000075000; -.
DR   HOGENOM; HOG000283250; -.
DR   HOVERGEN; HBG018967; -.
DR   InParanoid; O60762; -.
DR   KO; K00721; -.
DR   PhylomeDB; O60762; -.
DR   TreeFam; TF105617; -.
DR   BRENDA; 2.4.1.83; 2681.
DR   Reactome; R-HSA-162699; Synthesis of dolichyl-phosphate mannose.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; DPM1; human.
DR   GeneWiki; DPM1; -.
DR   GenomeRNAi; 8813; -.
DR   PRO; PR:O60762; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000000419; -.
DR   CleanEx; HS_DPM1; -.
DR   ExpressionAtlas; O60762; baseline and differential.
DR   Genevisible; O60762; HS.
DR   GO; GO:0033185; C:dolichol-phosphate-mannose synthase complex; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:HGNC.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004582; F:dolichyl-phosphate beta-D-mannosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IDA:HGNC.
DR   GO; GO:0019348; P:dolichol metabolic process; IDA:MGI.
DR   GO; GO:0006506; P:GPI anchor biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0035268; P:protein mannosylation; IDA:HGNC.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome.
DR   GO; GO:0035269; P:protein O-linked mannosylation; IDA:HGNC.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Congenital disorder of glycosylation;
KW   Congenital muscular dystrophy; Disease mutation; Dystroglycanopathy;
KW   Endoplasmic reticulum; Glycosyltransferase; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    260       Dolichol-phosphate mannosyltransferase
FT                                subunit 1.
FT                                /FTId=PRO_0000059170.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      92     92       R -> G (in CDG1E; dbSNP:rs121908583).
FT                                {ECO:0000269|PubMed:10642597,
FT                                ECO:0000269|PubMed:10642602}.
FT                                /FTId=VAR_012341.
FT   VARIANT     152    152       G -> V (in CDG1E; abolishes interaction
FT                                with DPM3; dbSNP:rs587777116).
FT                                {ECO:0000269|PubMed:23856421}.
FT                                /FTId=VAR_070592.
FT   VARIANT     248    248       S -> P (in CDG1E; dbSNP:rs587777114).
FT                                {ECO:0000269|PubMed:15669674}.
FT                                /FTId=VAR_019841.
FT   CONFLICT      9      9       S -> G (in Ref. 5; AAH08466).
FT                                {ECO:0000305}.
FT   CONFLICT     15     15       R -> W (in Ref. 6; AAC98797).
FT                                {ECO:0000305}.
FT   CONFLICT    135    135       Q -> K (in Ref. 6; AAC98797).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       V -> A (in Ref. 6; AAC98797).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       V -> I (in Ref. 6; AAC98797).
FT                                {ECO:0000305}.
FT   CONFLICT    177    177       R -> T (in Ref. 6; AAC98797).
FT                                {ECO:0000305}.
FT   CONFLICT    191    191       R -> P (in Ref. 6; AAC98797).
FT                                {ECO:0000305}.
FT   CONFLICT    220    220       L -> M (in Ref. 5; AAH08466).
FT                                {ECO:0000305}.
SQ   SEQUENCE   260 AA;  29634 MW;  9792145BFC8F0514 CRC64;
     MASLEVSRSP RRSRRELEVR SPRQNKYSVL LPTYNERENL PLIVWLLVKS FSESGINYEI
     IIIDDGSPDG TRDVAEQLEK IYGSDRILLR PREKKLGLGT AYIHGMKHAT GNYIIIMDAD
     LSHHPKFIPE FIRKQKEGNF DIVSGTRYKG NGGVYGWDLK RKIISRGANF LTQILLRPGA
     SDLTGSFRLY RKEVLEKLIE KCVSKGYVFQ MEMIVRARQL NYTIGEVPIS FVDRVYGESK
     LGGNEIVSFL KGLLTLFATT
//
